Immunology of bile acids regulated receptors

This publication has 384 references indexed in Scilit:

• Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver‐Distributed Farnesoid X‐Receptor Agonist TERN‐101 in Healthy Volunteers
  Clinical Pharmacology in Drug Development, 2021
• TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations
  European Journal of Immunology, 2018
• Design, Synthesis, and Structure–Activity Relationships of 3,4,5‐Trisubstituted 4,5‐Dihydro‐1,2,4‐oxadiazoles as TGR5 Agonists
  ChemMedChem, 2013
• Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes
  Clinical Pharmacology in Drug Development, 2013
• Physiology of Cholangiocytes
  2013
• 2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)
  ChemMedChem, 2012
• Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
  Hepatology, 2008
• Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence†
  Hepatology, 2008
• Functional Anatomy of Normal Bile Ducts
  The Anatomical Record, 2008
• Transforming growth factor-β and substrate stiffness regulate portal fibroblast activation in culture
  Hepatology, 2007